{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:22:00Z","timestamp":1791069720783,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.eplepsyres.2012.01.012","type":"journal-article","created":{"date-parts":[[2012,2,17]],"date-time":"2012-02-17T00:30:44Z","timestamp":1329438644000},"page":"93-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood\u2013brain barrier: A positron emission tomography study"],"prefix":"10.1016","volume":"100","author":[{"given":"Severin","family":"Mairinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens P.","family":"Bankstahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kuntner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"R\u00f6mermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Bankstahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Wanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Stanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Erker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2012.01.012_bib0005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00259-007-0556-5","article-title":"Peripheral metabolism of (R)-[11C]verapamil in epilepsy patients","volume":"35","author":"Abrahim","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"1","key":"10.1016\/j.eplepsyres.2012.01.012_bib0010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1124\/jpet.106.102491","article-title":"Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays","volume":"320","author":"Baltes","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.eplepsyres.2012.01.012_bib0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuropharm.2006.07.038","article-title":"Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein","volume":"52","author":"Baltes","year":"2007","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.eplepsyres.2012.01.012_bib0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.eplepsyres.2008.07.007","article-title":"Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus","volume":"82","author":"Bankstahl","year":"2008","journal-title":"Epilepsy Res."},{"issue":"24","key":"10.1016\/j.eplepsyres.2012.01.012_bib0025","doi-asserted-by":"crossref","first-page":"8803","DOI":"10.1523\/JNEUROSCI.6616-10.2011","article-title":"A novel PET imaging protocol identifies seizure-induced regional overactivity of P-glycoprotein at the blood\u2013brain barrier","volume":"31","author":"Bankstahl","year":"2011","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.eplepsyres.2012.01.012_bib0030","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.33.5.580","article-title":"Brain regional pharmacokinetics of 11C-labeled diphenylhydantoin: positron emission tomography in humans","volume":"33","author":"Baron","year":"1983","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.eplepsyres.2012.01.012_bib0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.nbd.2006.06.014","article-title":"The multidrug transporter hypothesis of drug resistance in epilepsy: proof-of-principle in a rat model of temporal lobe epilepsy","volume":"24","author":"Brandt","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.eplepsyres.2012.01.012_bib0040","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-3565(25)05109-2","article-title":"The role of the liver in the metabolic disposition of mephobarbital","volume":"106","author":"Butler","year":"1952","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.eplepsyres.2012.01.012_bib0045","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1124\/jpet.103.054304","article-title":"Functional expression of the multidrug resistance protein 1 in microglia","volume":"307","author":"Dallas","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.eplepsyres.2012.01.012_bib0050","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/14737140.7.4.447","article-title":"Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor","volume":"7","author":"Fox","year":"2007","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"8","key":"10.1016\/j.eplepsyres.2012.01.012_bib0055","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s11095-007-9502-2","article-title":"On the rate and extent of drug delivery to the brain","volume":"25","author":"Hammarlund-Udenaes","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.eplepsyres.2012.01.012_bib0060","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/0883-2889(92)90012-4","article-title":"A simple synthesis of [11C]methyl triflate","volume":"43","author":"Jewett","year":"1992","journal-title":"Appl. Radiat. Isot."},{"issue":"4","key":"10.1016\/j.eplepsyres.2012.01.012_bib0065","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/clpt.2009.138","article-title":"Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications","volume":"86","author":"Kannan","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.eplepsyres.2012.01.012_bib0070","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1007\/s00259-009-1332-5","article-title":"Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood\u2013brain barrier using (R)-[11C]verapamil PET","volume":"37","author":"Kuntner","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"2","key":"10.1016\/j.eplepsyres.2012.01.012_bib0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0969-8043(96)00177-7","article-title":"Synthesis of [11C]iodomethane by iodination of [11C]methane","volume":"48","author":"Larsen","year":"1997","journal-title":"Appl. Radiat. Isot."},{"issue":"8","key":"10.1016\/j.eplepsyres.2012.01.012_bib0080","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn1728","article-title":"Drug resistance in brain diseases and the role of drug efflux transporters","volume":"6","author":"L\u00f6scher","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.eplepsyres.2012.01.012_bib0085","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pneurobio.2005.04.006","article-title":"Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases","volume":"76","author":"L\u00f6scher","year":"2005","journal-title":"Prog. Neurobiol."},{"issue":"26","key":"10.1016\/j.eplepsyres.2012.01.012_bib0090","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.2174\/138161211797440212","article-title":"Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected","volume":"17","author":"L\u00f6scher","year":"2011","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"10.1016\/j.eplepsyres.2012.01.012_bib0095","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.neuropharm.2008.08.032","article-title":"Several major antiepileptic drugs are substrates for human P-glycoprotein","volume":"55","author":"Luna-Tort\u00f3s","year":"2008","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.eplepsyres.2012.01.012_bib0100","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.neuropharm.2010.01.007","article-title":"Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy","volume":"58","author":"Luna-Tort\u00f3s","year":"2010","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.eplepsyres.2012.01.012_bib0105","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2174\/138920011798356980","article-title":"PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo","volume":"12","author":"Mairinger","year":"2011","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.eplepsyres.2012.01.012_bib0110","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1749-6632.1991.tb37972.x","article-title":"Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist","volume":"629","author":"Margolskee","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"8","key":"10.1016\/j.eplepsyres.2012.01.012_bib0115","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s11095-009-9896-0","article-title":"Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs","volume":"26","author":"Matsson","year":"2009","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.eplepsyres.2012.01.012_bib0120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(02)00423-8","article-title":"P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood\u2013brain barrier: evidence from microdialysis experiments in rats","volume":"327","author":"Potschka","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"2-3","key":"10.1016\/j.eplepsyres.2012.01.012_bib0125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0920-1211(98)00106-5","article-title":"Clinical aspects and biological bases of drug-resistant epilepsies","volume":"34","author":"Regesta","year":"1999","journal-title":"Epilepsy Res."},{"issue":"Pt. 1","key":"10.1016\/j.eplepsyres.2012.01.012_bib0130","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/brain\/awh682","article-title":"Molecular and cellular mechanisms of pharmacoresistance in epilepsy","volume":"129","author":"Remy","year":"2006","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.eplepsyres.2012.01.012_bib0135","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0020-708X(81)90163-0","article-title":"The synthesis of some C-11-labeled anti-epileptic drugs with potential utility as radiopharmaceuticals \u2013 hydantoins and barbiturates","volume":"32","author":"Roeda","year":"1981","journal-title":"Int. J. Appl. Radiat. Isot."},{"issue":"4","key":"10.1016\/j.eplepsyres.2012.01.012_bib0140","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1528-1167.2006.00496.x","article-title":"Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats","volume":"47","author":"van Vliet","year":"2006","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.eplepsyres.2012.01.012_bib0145","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.2967\/jnumed.109.063289","article-title":"A pilot study to assess the efficacy of tariquidar to inhibit P-glycoprotein at the human blood\u2013brain barrier with (R)-11C-verapamil and PET","volume":"50","author":"Wagner","year":"2009","journal-title":"J. Nucl. Med."},{"issue":"23-24","key":"10.1016\/j.eplepsyres.2012.01.012_bib0150","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.lfs.2010.04.008","article-title":"In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein","volume":"86","author":"Zhang","year":"2010","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.eplepsyres.2012.01.012_bib0155","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1528-1167.2011.03140.x","article-title":"In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein","volume":"52","author":"Zhang","year":"2011","journal-title":"Epilepsia"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121112000320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121112000320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:28:14Z","timestamp":1760275694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121112000320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0920121112000320"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.01.012","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood\u2013brain barrier: A positron emission tomography study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2012.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}